TIDMSEED
Seed Innovations Limited
17 January 2022
Seed Innovations Ltd / AIM: SEED / Sector: Closed End
Investments
17 January 2022
SEED Innovations Limited ("SEED" or the "Company")
Investee Company Update: Yooma Wellness Inc.
SEED Innovations Ltd, the AIM quoted company investing in fast
growing and industry leading businesses with a focus on the medical
cannabis, health and wellness space, is pleased to note an update
by its portfolio company, Yooma Wellness Inc. ('Yooma'), a global
vertically integrated wellness platform that develops and markets a
portfolio of CBD and wellness brands.
Yooma has announced that Boots, Britain 's leading health and
beauty retailer, will be stocking MYO Plant Nutrition brand ('MYO')
in over 800 stores. The UK-based, 100%-plant built, nutrition
business was acquired by Yooma in March 2021 and currently has its
products available in Holland & Barrett, Selfridges, Lloyds
Pharmacy and Amazon. Boots will be stocking MYO's branched-chain
amino acids, essential amino acids and functional spray products in
stores.
SEED has a holding of 4,427,609 ordinary shares in Yooma
representing approximately 4.4% of Yooma's issued share
capital.
Ed McDermott, CEO of SEED, commented : " We are pleased with the
progress Yooma is making in the wellness and CBD sectors through
its buy-and-build strategy. Boots is a major market leader in the
UK health and beauty industry and we hope that this new
relationship will create further shareholder value through this
wide exposure and distribution of MYO."
The announcement by Yooma Wellness Inc is set out below without
material changes or adjustments:
17 January 2022
MYO Plant Nutrition launches in Boots across the UK
Products available in up to 838 stores across the UK
Yooma Wellness Inc. (CSE:YOOM; AQSE:YOOM), a global vertically
integrated wellness platform that develops and markets a portfolio
of CBD and wellness brands, is pleased to announce that Boots, the
UK's leading health and beauty retailer, will stock MYO Plant
Nutrition ('MYO') products.
The listing includes MYO's Plant Proteins in 838 stores,
branched-chain amino acids (BCAA) and essential amino acids (EAA)
in up to 574 stores, and functional sprays in 522 stores.
Launching with Boots accelerates the momentum MYO has already
seen in 2021, with products now available in Holland & Barrett,
Selfridges, Lloyds Pharmacy and Amazon, amongst others.
MYO products are 100 %-plant-based, use clean and innovative
ingredients, and focus on the growing area of full-body plant-based
wellness, which includes nutrition, the gut, brain, immunity and
other key elements of wellness. Furthermore, MYO holds a leading
position with regards to sustainability by using recycled and
recyclable outer packaging as well as biodegradable scoops and
pouches.
James Lawson Baker, Founder of MYO Plant Nutrition, commented:
"This is a major milestone for MYO and we are absolutely delighted
to be partnering with Boots, the leading health and beauty retailer
in the UK. A listing of this size gives the brand enormous national
exposure and deepens our footprint within mainstream UK retail. The
listing will support MYO in making plant-based active nutrition and
wellness products mainstream and accessible. The partnership is a
testament to the high-quality product and brand offering that we
have built over the past year. We look forward to building our
credibility amongst Boots' customers going forward."
Jordan Greenberg, CEO of Yooma , said: "MYO Plant Nutrition is
an exceptional example of how Yooma's buy-and-build strategy
creates shareholder value. MYO continues to surpass expectations
with its increased availability in UK's most reputable retailers
and it has the honour of being known as one of the few brands to
have passed the FSA's validation assessment."
Yooma acquired MYO in March 2021, due to the growing market
demand for p lant-based protein supplements, with a global market
size estimated at US$4.3 billion in 2020, projected to grow at a
CAGR of 7.2% during a forecast period 2021-2026.
About MYO Plant Nutrition
MYO Plant Nutrition is a UK-based plant nutrition business with
a mission to help people improve their full-body wellness. With a
comprehensive product portfolio, MYO helps address the key areas of
wellness including nutrition, performance, immunity, cognitive
health and gut health. MYO is one of the few brands whose CBD
products have passed the UK Food Standard Agency's ("FSA") rigorous
validation assessment and a number of products are included on the
FSA's public list. The brand is stocked in Boots, Holland &
Barrett and Lloyds Pharmacy amongst others. For further information
visit www.myoplantnutrition.com .
About Yooma Wellness Inc.
Yooma's mission is to build a vertically-integrated global
leader in the manufacturing, marketing, distribution, and sale of
wellness products including hemp seed oil and hemp-derived and
cannabinoid (CBD) ingredients. The Company leverages strategically
curated sales channels and ecommerce networks to deliver a diverse
mix of wellness products through operating subsidiaries in the
United States, United Kingdom, France and Japan. Learn more at
www.yooma.ca .
***ENDS***
For further information on the Company please visit
www.seedinnovations.co or contact:
Ed McDermott SEED Innovations E: info@seedinnovations.co
Lance de Jersey Ltd
James Biddle Beaumont Cornish T: (0)20 7628 3396
Roland Cornish Limited,
Nomad
------------------- -------------------------------
Isabella Pierre Shard Capital T: (0)20 7186 9927
Damon Heath Partners LLP
Broker
------------------- -------------------------------
Catherine Leftley St Brides Partners E: info@stbridespartners.co.uk
Isabelle Morris Ltd,
Financial PR
------------------- -------------------------------
Notes
SEED Innovations is an AIM quoted investment company focused
primarily on disruptive high growth life sciences and technology
businesses particularly within the medical cannabis arena. The
Company's strategy is to identify early-stage opportunities that
have an upcoming investment catalyst and grow its portfolio in
terms of value whilst limiting the number of investee companies to
a level where relevant time can be devoted to each.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAFLFLSLSIDLIF
(END) Dow Jones Newswires
January 17, 2022 09:30 ET (14:30 GMT)
Fastforward Innovations (LSE:FFWD)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Fastforward Innovations (LSE:FFWD)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024
